Related Experiment Video
Updated: Jun 15, 2026

Measuring Caspase Activity Using a Fluorometric Assay or Flow Cytometry
Published on: March 24, 2023
Increased caspase-2 activity is associated with induction of apoptosis in IFN-beta sensitive melanoma cell lines
Takafumi Kamiya1, Tamaki Okabayashi, Shin-Ichi Yokota
1Department of Dermatology, Sapporo Medical University School of Medicine , Sapporo, Hokkaido, Japan.
Abstract:
Interferon (IFN) is believed to be one of the most effective anti-melanoma agents. Specifically, IFN-beta has the ability to induce apoptosis of melanoma cells. Induction of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has also been suggested to have a critical role in IFN-beta-induced apoptosis. To characterize the signaling pathway involved in IFN-beta-induced apoptosis, we analyzed the biological effects of IFN-beta on the cell death and caspase activation of melanoma cells. IFN-sensitive cell lines, MM418, SK-mel-23, and SK-mel-118, showed increased apoptotic populations correlated with the activation of caspase-2 and caspase-3 by IFN-beta. IFN-beta-induced apoptosis was significantly suppressed by inhibitors for caspase-2 or caspase-3, but not by inhibitors for caspase-8 or caspase-9 in these cell lines. TRAIL expression was observed in IFN-beta-treated cells of SK-mel-23 and SK-mel-118, but not in those cells of MM418, which showed massive IFN-beta-induced apoptosis and resistance to exogenous TRAIL-mediated apoptosis. G361 was resistant to IFN-beta-induced apoptosis but sensitive to exogenous TRAIL-mediated apoptosis. Furthermore, IFN-beta pretreatment significantly increased the sensitivity against exogenous TRAIL-mediated apoptosis and activation of caspase-2 in G361. These results suggested that caspase-2 activation is commonly associated with induction of IFN-beta-induced apoptosis in IFN-beta-sensitive melanoma cells.
Insights
Interferon-beta (IFN-beta) effectively induces melanoma cell death by activating caspase-2 and caspase-3. This study reveals caspase-2 activation as a key mechanism in IFN-beta-driven apoptosis for sensitive melanoma cells.
Area of Science:
- Oncology
- Immunology
- Cell Biology
Background:
- Interferon (IFN) is a potent anti-melanoma agent.
- IFN-beta specifically induces apoptosis in melanoma cells.
- Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) may play a role in IFN-beta-induced apoptosis.
Purpose of the Study:
- To investigate the signaling pathway of IFN-beta-induced apoptosis in melanoma.
- To analyze the effects of IFN-beta on melanoma cell death and caspase activation.
Main Methods:
- Assessed melanoma cell lines (MM418, SK-mel-23, SK-mel-118, G361) for apoptosis and caspase activation after IFN-beta treatment.
- Utilized caspase inhibitors (caspase-2, -3, -8, -9) to determine pathway involvement.
- Examined TRAIL expression and sensitivity to exogenous TRAIL.
Main Results:
- IFN-beta increased apoptosis and activated caspase-2 and caspase-3 in IFN-sensitive cell lines (MM418, SK-mel-23, SK-mel-118).
- Apoptosis was inhibited by caspase-2 or caspase-3 inhibitors, but not caspase-8 or -9 inhibitors.
- TRAIL expression varied; MM418 showed resistance to TRAIL, while G361 (resistant to IFN-beta) became sensitive after IFN-beta pretreatment, with increased caspase-2 activation.
Conclusions:
- Caspase-2 activation is a common factor in IFN-beta-induced apoptosis in sensitive melanoma cells.
- The study clarifies the specific caspase pathways involved in IFN-beta's anti-melanoma effects.
Related Concept Videos
Caspases
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Apoptosis
Cellular Injury V: Apoptosis and Autophagy

